miércoles, 9 de septiembre de 2026

A breakthrough pancreatic cancer drug won approval. They still struggle to access it Patients who had hoped to get expanded access have found themselves in a maddening limbo

https://www.statnews.com/2026/09/08/pancreatic-cancer-patients-caught-beween-fda-drug-approval-insurance-coverage/ By Angus ChenSept. 8, 2026 Cancer Reporter

No hay comentarios: